Research ExplorerJournalsONCOTARGET Publications

ONCOTARGET

51 - 100 out of 125Page size: 50

Publications

  1. 2017

  2. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia

    Boer, J. M., Steeghs, E. M. P., Marchante, J. R. M., Boeree, A., Beaudoin, J. J., Beverloo, H. B., Kuiper, R. P., Escherich, G., van der Velden, V. H. J., van der Schoot, C. E., de Groot-Kruseman, H. A., Pieters, R. & den Boer, M. L., 01.2017, In: ONCOTARGET. 8, 3, p. 4618-4628

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Analyzing the influence of kinase inhibitors on DNA repair by differential proteomics of chromatin-interacting proteins and nuclear phospho-proteins

    Gleißner, L., Kwiatkowski, M., Myllynen, L., Steffen, P., Petersen, C., Rothkamm, K., Schlüter, H. & Kriegs, M., 2017, In: ONCOTARGET. 8, 67, p. 110983-110993

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2016

  5. Deletion of 18q is a strong and independent prognostic feature in prostate cancer

    Kluth, M., Graunke, M., Koop, C., Hube-Magg, C., Minner, S., Michl, U., Graefen, M., Huland, H., Pompe, R., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Büscheck, F., Clauditz, T., Wilczak, W., Sauter, G., Schlomm, T. & Simon, R., 27.12.2016, In: ONCOTARGET. 7, 52, p. 86339-86349 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. TSC loss distorts DNA replication programme and sensitises cells to genotoxic stress

    Pai, G. M., Zielinski, A., Koalick, D., Ludwig, K., Wang, Z-Q., Borgmann, K., Pospiech, H. & Rubio, I., 20.12.2016, In: ONCOTARGET. 7, 51, p. 85365-85380

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

    Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemaçon, A., Droit, A., Andrulis, I. L., Anton-Culver, H., Arndt, V., Baynes, C., Blomqvist, C., Bogdanova, N. V., Bojesen, S. E., Bolla, M. K., Bonanni, B., Borresen-Dale, A-L., Brand, J. S., Brauch, H., Brenner, H., Broeks, A., Burwinkel, B., Chang-Claude, J., Couch, F. J., Cox, A., Cross, S. S., Czene, K., Darabi, H., Dennis, J., Devilee, P., Dörk, T., Dos-Santos-Silva, I., Eriksson, M., Fasching, P. A., Figueroa, J., Flyger, H., García-Closas, M., Giles, G., Goldberg, M. S., González-Neira, A., Grenaker Alnæs, G., Guénel, P., Haeberle, L., Haiman, C. A., Hamann, U., Hallberg, E., Hooning, M. J., Hopper, J. L., Jakubowska, A., Jones, M., Kabisch, M., Kataja, V., Lambrechts, D., Le Marchand, L., Lindblom, A., Lubinski, J., Mannermaa, A., Maranian, M. J., Margolin, S., Marme, F., Milne, R. L., Neuhausen, S. L., Nevanlinna, H., Neven, P., Olswold, C., Peto, J., Plaseska-Karanfilska, D., Pylkäs, K., Radice, P., Rudolph, A., Sawyer, E. J., Schmidt, M. K., Shu, X-O., Southey, M. C., Swerdlow, A., Tollenaar, R. A. E. M., Tomlinson, I., Torres, D., Truong, T., Vachon, C., Ouweland, A. M. W. V. D., Wang, Q., Winqvist, R., Zheng, W., Benitez, J., Chenevix-Trench, G., Dunning, A. M., Pharoah, P. D. P., Kristensen, V., Hall, P., Easton, D. F., Pastinen, T., Nord, S., Simard, J. & NBCS Collaborators, 06.12.2016, In: ONCOTARGET. 7, 49, p. 80140-80163 24 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

    Lebok, P., Roming, M., Kluth, M., Koop, C., Ozden, C., Taskin, B., Hussein, K., Lebeau, A., Witzel, I., Wölber, L., Geist, S., Paluchowski, P., Wilke, C., Heilenkötter, U., Müller, V., Schmalfeldt, B., Simon, R., Sauter, G., Terracciano, L., Krech, R. H., von der Assen, A. & Burandt, E., 06.12.2016, In: ONCOTARGET. 7, 49, p. 81322-81331

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells

    Taipaleenmäki, H., Farina, N. H., van Wijnen, A. J., Stein, J. L., Hesse, E., Stein, G. S. & Lian, J. B., 29.11.2016, In: ONCOTARGET. 7, 48, p. 79032-79046

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins

    Lars Björn, R., Zoch, A., Wiehl, U., Reichert, S., Scholl, I., Cui, Y., Ziemer, M., Anderegg, U., Hagel, C. & Morrison, H., 29.11.2016, In: ONCOTARGET. 7, 48, p. 78242-78254

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Akt isoform specific effects in ovarian cancer progression

    Linnerth-Petrik, N. M., Santry, L. A., Moorehead, R., Jücker, M., Wootton, S. K. & Petrik, J., 15.11.2016, In: ONCOTARGET. 7, 46, p. 74820-74833 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

    Permuth, J. B., Reid, B., Earp, M., Chen, A. Y., Monteiro, A. N. A., Chen, Z., Chenevix-Trench, G., Fasching, P. A., Lambrechts, D., Vanderstichele, A., Van Niewenhuyse, E., Vergote, I., Rossing, M. A., Doherty, J. A., Chang-Claude, J., Moysich, K. B., Odunsi, K., Goodman, M. T., Shvetsov, Y. B., Wilkens, L. R., Thompson, P. J., Dörk, T., Bogdanova, N., Butzow, R., Nevanlinna, H., Pelttari, L. M., Leminen, A., Modugno, F., Edwards, R. P., Ness, R. B., Kelley, J. L., Heitz, F., Karlan, B., Lester, J., Kjaer, S. K., Jensen, A., Giles, G., T Hildebrandt, M. A., Liang, D., Lu, K. H., Wu, X., Levine, D. A., Bisogna, M., Berchuck, A., Cramer, D. W., Terry, K. L., Tworoger, S. S., Poole, E. M., Bandera, E. V., Fridley, B. L., Cunningham, J. M., Winham, S. J., Olson, S. H., Orlow, I., Bjorge, L., Kiemeney, L. A., Massuger, L. F. A. G., Pejovic, T., Moffitt, M., Le, N. D., Cook, L. S., Brooks-Wilson, A., Kelemen, L. E., Gronwald, J., Lubinski, J., Wentzensen, N., Brinton, L. A., Lissowska, J., Yang, H. P., Hogdall, E., Hogdall, C., Lundvall, L., Pharoah, P. D. P., Song, H., Campbell, I., Eccles, D., McNeish, I., Whittemore, A. S., McGuire, V., Sieh, W., Rothstein, J., Phelan, C. M., Risch, H. A., Narod, S. A., McLaughlin, J. R., Anton-Culver, H., Ziogas, A., Menon, U., Gayther, S. A., Ramus, S. J., Gentry-Maharaj, A., Pearce, C. L., Wu, A. H., Kupryjanczyk, J., Dansonka-Mieszkowska, A., Schildkraut, J. M., Cheng, J. Q., Goode, E. L., Sellers, T. A. & AOCS study group, 08.11.2016, In: ONCOTARGET. 7, 45, p. 72381-72394 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L

    Najem, S., Langemann, D., Appl, B., Trochimiuk, M., Hundsdoerfer, P., Reinshagen, K. & Eschenburg, G., 08.11.2016, In: ONCOTARGET. 7, 45, p. 72634-72653

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells

    Fielitz, K., Althoff, K., De Preter, K., Nonnekens, J., Ohli, J., Elges, S., Hartmann, W., Klöppel, G., Knösel, T., Schulte, M., Klein-Hitpass, L., Beisser, D., Reis, H., Eyking, A., Cario, E., Schulte, J. H., Schramm, A. & Schüller, U., 19.10.2016, In: ONCOTARGET. 7, 46, p. 74415-74426

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis

    Goertz, L., Schneider, S. W., Desch, A., Mayer, F. T., Koett, J., Nowak, K., Karampinis, I., Bohlmann, M. K., Umansky, V. & Bauer, A. T., 18.10.2016, In: ONCOTARGET. 7, 42, p. 68527-68545 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins

    Schieferdecker, A., Shoshani, O., Westner, B., Zipori, D., Fehse, B., Kröger, N. & Ayuketang, F. A., 11.10.2016, In: ONCOTARGET. 7, 41, p. 67061-67070

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo

    Wegwitz, F., Lenfert, E., Gerstel, D., von Ehrenstein, L., Einhoff, J., Schmidt, G., Logsdon, M., Brandner, J., Tiegs, G., Beauchemin, N., Wagener, C., Deppert, W. & Horst, A. K., 27.09.2016, In: ONCOTARGET. 7, 39, p. 63730-63746

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines

    Riedel, M., Struve, N., Müller-Goebel, J., Köcher, S., Petersen, C., Dikomey, E., Rothkamm, K. & Kriegs, M., 20.09.2016, In: ONCOTARGET. 7, 38, p. 61988-61995

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1

    Bakr, A., Köcher, S., Volquardsen, J., Petersen, C., Borgmann, K., Dikomey, E., Rothkamm, K. & Mansour Khalfallah, W. Y., 06.09.2016, In: ONCOTARGET. 7, 36, p. 57679-57693

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer

    Schmitz, R., Valls, A. F., Yerbes, R., von Richter, S., Kahlert, C., Loges, S., Weitz, J., Schneider, M., Ruiz de Almodovar, C., Ulrich, A. & Schmidt, T., 30.08.2016, In: ONCOTARGET. 7, 35, p. 56355-56370 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response

    Heim, D., Gil-Ibanez, I., Herden, J., Parplys, A. C., Borgmann, K., Schmidt-Arras, D., Lohse, A. W., Rose-John, S. & Wege, H., 23.08.2016, In: ONCOTARGET. 7, 34, p. 55639-55648

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. β-MSCs: successful fusion of MSCs with β-cells results in a beta-cell like phenotype

    Azizi-Varzaneh, Z., Lange, C., Paroni, F., Ardestani, A., Meyer, A., Wu, Y., Zander, A. R., Westenfelder, C. & Maedler, K., 02.08.2016, In: ONCOTARGET. 7, 31, p. 48963-48977

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests

    Kriegs, M., Kasten-Pisula, U., Riepen, B., Hoffer, K., Struve, N., Myllynen, L., Braig, F., Binder, M., Rieckmann, T., Grénman, R., Petersen, C., Dikomey, E. & Rothkamm, K., 19.07.2016, In: ONCOTARGET. 7, 29, p. 45122-45133

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia

    Lopes, B. A., Meyer, C., Barbosa, T. C., Stadt, U. Z., Horstmann, M., Venn, N. C., Heatley, S., White, D. L., Sutton, R., Pombo-de-Oliveira, M. S., Marschalek, R. & Emerenciano, M., 13.07.2016, In: ONCOTARGET. 7, 33, p. 53064-53073

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer

    Toulany, M., Iida, M., Keinath, S., Iyi, F. F., Mueck, K., Fehrenbacher, B., Mansour Khalfallah, W. Y., Schaller, M., Wheeler, D. L. & Rodemann, H. P., 12.07.2016, In: ONCOTARGET. 7, 28, p. 43746-43761 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein

    Warsito, D., Lin, Y., Gnirck, A-C., Sehat, B. & Larsson, O., 05.07.2016, In: ONCOTARGET. 7, 27, p. 42288-42302 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer

    Gorges, T. M., Riethdorf, S., von Ahsen, O., Nastały, P., Röck, K., Boede, M., Peine, S., Kuske, A., Schmid, E., Kneip, C., König, F., Rudolph, M. & Pantel, K., 07.06.2016, In: ONCOTARGET. 7, 23, p. 34930-41

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

    Vey, N., Delaunay, J., Martinelli, G., Fiedler, W., Raffoux, E., Prebet, T., Gomez-Roca, C., Papayannidis, C., Kebenko, M., Paschka, P., Christen, R., Guarin, E., Bröske, A-M., Baehner, M., Brewster, M., Walz, A-C., Michielin, F., Runza, V., Meresse, V. & Recher, C., 31.05.2016, In: ONCOTARGET. 7, 22, p. 32532-42

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET

    Beer, A. J., Schwarzenbock, S. M., Zantl, N., Souvatzoglou, M., Maurer, T., Watzlowik, P., Kessler, H., Wester, H. J., Schwaiger, M. & Krause, B. J., 10.05.2016, In: ONCOTARGET. 7, 19, p. 28151-28159 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  30. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells

    Möckelmann, N., Rieckmann, T., Busch, C-J., Becker, B., Gleißner, L., Hoffer, K., Omniczynski, M., Steinmeister, L., Laban, S., Grénman, R., Petersen, C., Rothkamm, K., Dikomey, E., Knecht, R. & Kriegs, M., 26.04.2016, In: ONCOTARGET. 7, 17, p. 23542-51 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines

    Busch, C-J., Becker, B., Kriegs, M., Gatzemeier, F., Krüger, K., Möckelmann, N., Fritz, G., Petersen, C., Knecht, R., Rothkamm, K. & Rieckmann, T., 26.04.2016, In: ONCOTARGET. 7, 24, p. 35832-35842

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma

    Braig, F., Voigtländer, M., Schieferdecker, A., Busch, C-J., Laban, S., Grob, T., Kriegs, M., Knecht, R., Bokemeyer, C. & Binder, M., 22.04.2016, In: ONCOTARGET. 7, 28, p. 42988-42995

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Tenascin-C serum levels and its prognostic power in non-small cell lung cancer

    Gebauer, F., Gelis, S., Zander, H., Meyer, K-F., Wolters-Eisfeld, G., Izbicki, J. R., Bockhorn, M. & Tachezy, M., 12.04.2016, In: ONCOTARGET. 7, 15, p. 20945-52 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis

    Müller, M., Wetzel, S., Köhn-Gaone, J., Chalupsky, K., Lüllmann-Rauch, R., Barikbin, R., Bergmann, J., Wöhner, B., Zbodakova, O., Leuschner, I., Martin, G., Tiegs, G., Rose-John, S., Sedlacek, R., Tirnitz-Parker, J. E. E., Saftig, P. & Schmidt-Arras, D., 05.04.2016, In: ONCOTARGET. 7, 14, p. 17431-41 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer

    Meng, X., Müller, V., Milde-Langosch, K., Trillsch, F., Pantel, K. & Schwarzenbach, H., 29.03.2016, In: ONCOTARGET. 7, 13, p. 16923-35

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

    Schmidt, M., Mock, A., Jungk, C., Sahm, F., Ull, A. T., Warta, R., Lamszus, K., Gousias, K., Ketter, R., Roesch, S., Rapp, C., Schefzyk, S., Urbschat, S., Lahrmann, B., Kessler, A. F., Löhr, M., Senft, C., Grabe, N., Reuss, D., Beckhove, P., Westphal, M., von Deimling, A., Unterberg, A., Simon, M. & Herold-Mende, C., 22.03.2016, In: ONCOTARGET. 7, 12, p. 14551-68 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab

    Haen, S. P., Schmiedel, B. J., Rothfelder, K., Schmied, B. J., Dang, T-M., Mirza, N., Möhle, R., Kanz, L., Vogel, W. & Salih, H. R., 15.03.2016, In: ONCOTARGET. 7, 11, p. 13013-30 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response

    Wurster, S., Hennes, F., Parplys, A. C., Seelbach, J. I., Mansour Khalfallah, W. Y., Zielinski, A., Petersen, C., Clauditz, T. S., Münscher, A., Friedl, A. A. & Borgmann, K., 01.03.2016, In: ONCOTARGET. 7, 9, p. 9732-41

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. RHAMM splice variants confer radiosensitivity in human breast cancer cell lines

    Schütze, A., Vogeley, C., Gorges, T., Twarock, S., Butschan, J., Babayan, A., Klein, D., Knauer, S. K., Metzen, E., Müller, V., Jendrossek, V., Pantel, K., Milde-Langosch, K., Fischer, J. W. & Röck, K., 08.02.2016, In: ONCOTARGET. 7, 16, p. 21428-40

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

    Kluth, M., Meyer, D., Krohn, A., Freudenthaler, F., Bauer, M., Salomon, G., Heinzer, H., Michl, U., Steurer, S., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 26.01.2016, In: ONCOTARGET. 7, 4, p. 3897-904

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma

    Darb-Esfahani, S., Kunze, C. A., Kulbe, H., Sehouli, J., Wienert, S., Lindner, J., Budczies, J., Bockmayr, M., Dietel, M., Denkert, C., Braicu, I. & Jöhrens, K., 12.01.2016, In: ONCOTARGET. 7, 2, p. 1486-99 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer

    Dyshlovoy, S. A., Otte, K., Alsdorf, W. H., Hauschild, J., Lange, T., Venz, S., Bauer, C. K., Bähring, R., Amann, K., Mandanchi, R., Schumacher, U., Schröder-Schwarz, J., Makarieva, T. N., Guzii, A. G., Tabakmakher, K. M., Fedorov, S. N., Shubina, L. K., Kasheverov, I. E., Ehmke, H., Steuber, T., Stonik, V. A., Bokemeyer, C., Honecker, F. & von Amsberg, G., 2016, In: ONCOTARGET. 7, 43, p. 69703 - 69717

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy

    Bruns, M., Wanger, J., Schumacher, U. & Deppert, W., 2016, In: ONCOTARGET. 7, 40, p. 64543 - 64559

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. 2015

  45. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases

    Harter, P. N., Bernatz, S., Scholz, A., Zeiner, P. S., Zinke, J., Kiyose, M., Blasel, S., Beschorner, R., Senft, C., Bender, B., Ronellenfitsch, M. W., Wikman-Kocher, H., Glatzel, M., Meinhardt, M., Juratli, T. A., Steinbach, J. P., Plate, K. H., Wischhusen, J., Weide, B. & Mittelbronn, M., 12.2015, In: ONCOTARGET. 6, 38, p. 40836-40849

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses

    Bruns, M., Wanger, J., Utermöhlen, O. & Deppert, W., 17.11.2015, In: ONCOTARGET. 6, 36, p. 38487-503 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

    Clifford, S. C., Lannering, B., Schwalbe, E. C., Hicks, D., O'Toole, K., Nicholson, S. L., Goschzik, T., Zur Mühlen, A., Figarella-Branger, D., Doz, F., Rutkowski, S., Gustafsson, G., Pietsch, T. & SIOP-Europe PNET Group, 17.11.2015, In: ONCOTARGET. 6, 36, p. 38827-39 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells

    Struve, N., Riedel, M., Schulte, A., Rieckmann, T., Grob, T. J., Gal, A., Rothkamm, K., Lamszus, K., Petersen, C., Dikomey, E. & Kriegs, M., 20.10.2015, In: ONCOTARGET. 6, 32, p. 33867-77 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours

    Bremmer, F., Schallenberg, S., Jarry, H., Küffer, S., Kaulfuss, S., Burfeind, P., Strauß, A., Thelen, P., Radzun, H. J., Ströbel, P., Honecker, F. & Behnes, C. L., 20.10.2015, In: ONCOTARGET. 6, 32, p. 33426-37 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma

    Lennerz, J. K., Hoffmann, K., Bubolz, A-M., Lessel, D., Welke, C., Rüther, N., Viardot, A. & Möller, P., 06.10.2015, In: ONCOTARGET. 6, 30, p. 29097-110 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 29.09.2015, In: ONCOTARGET. 6, 29, p. 27966-79 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression

    Bednarz-Knoll, N., Nastały, P., Żaczek, A., Stoupiec, M., Riethdorf, S., Wikman-Kocher, H., Müller, V., Skokowski, J., Szade, J., Sejda, A., Wełnicka-Jaśkiewicz, M. & Pantel, K., 29.09.2015, In: ONCOTARGET. 6, 29, p. 26789-803 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. HMGB1 and injury amplification

    Hübener, P., Hernandez, C. & Schwabe, R. F., 15.09.2015, In: ONCOTARGET. 6, 27, p. 23048-9

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Previous 1 2 3 Next